Investigational New Drugs logo Springer logo

Publisher: Springer

Related content
Volume 21, Number 1, February 2003

all issues

Effect of the Antitumor Drug Vinblastine on Nuclear II-tubulin in Cultured Rat Kidney Mesangial Cells
pp. 15-20(6)
Authors: Walss-Bass, C.; Kreisberg, J.I.; Ludueña, R.F.

Reversal of Tumor-induced Immunosuppression by TGF- Inhibitors
pp. 21-32(12)
Author: Wojtowicz-Praga, S.

Discovery and Preclinical Antitumor Efficacy Evaluations of LY32262 and LY33169
pp. 33-45(13)
Authors: Corbett, T.H.; White, K.; Polin, L.; Kushner, J.; Paluch, J.; Shih, C.; Grossman, C.S.

A Phase I Clinical Trial of Spicamycin Derivative KRN5500 (NSC 650426) Using a Phase I Accelerated Titration “2B” Design
pp. 63-74(12)
Authors: Gadgeel, S.M.; Boinpally, R.R.; Heilbrun, L.K.; Wozniak, A.; Jain, V.; Redman, B.; Zalupski, M.; Wiegand, R.; Parchment, R.; LoRusso, P.M.

A Phase I and Pharmacologic Study of Pyrazoloacridine and Cisplatin in Patients with Advanced Cancer
pp. 75-84(10)
Authors: Claire Dees, E.; Rowinsky, E.K.; Noe, D.A.; O'Reilly, S.; Adjei, A.A.; Elza-Brown, K.; Donehower, R.C.

Phase I and Pharmacologic Study of the Human DNA Methyltransferase Antisense Oligodeoxynucleotide MG98 given as a 21-day Continuous Infusion Every 4 Weeks
pp. 85-97(13)
Authors: Davis, A.J.; Gelmon, K.A.; Siu, L.L.; Moore, M.J.; Britten, C.D.; Mistry, N.; Klamut, H.; D'Aloisio, S.; MacLean, M.; Wainman, N.; Ayers, D.; Firby, P.; Besterman, J.M.; Reid, G.K.; Eisenhauer, E.A.

Phase II Trial of Antiepidermal Growth Factor Receptor Antibody C225 in Patients with Advanced Renal Cell Carcinoma
pp. 99-101(3)
Authors: Motzer, R.J.; Amato, R.; Todd, M.; Poo Hwu, W-J.; Cohen, R.; Baselga, J.; Muss, H.; Cooper, M.; Yu, R.; Ginsberg, M.S.; Needle, M.

A Phase II Study of Rebeccamycin Analog NSC 655649 in Patients with Metastatic Colorectal Cancer
pp. 103-107(5)
Authors: Goel, S.; Wadler, S.; Hoffman, A.; Volterra, F.; Baker, C.; Nazario, E.; Ivy, P.; Silverman, A.; Mani, S.

Phase II Study of Single Agent Paclitaxel in Adult Patients with Relapsed Acute Lymphocytic Leukemia
pp. 109-111(3)
Authors: Colburn, D.E.; Thomas, D.A.; Giles, F.J.

Current Approaches to Novel Therapeutics in Pancreatic Cancer
pp. 113-129(17)
Authors: Akerele, C.E.; Rybalova, I.; Kaufman, H.L.; Mani, S.

all issues

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page